Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs.

Yamamoto, Wataru; Hashimoto, Norio; Matsuura, Junji; Machida, Taiichi; Ogino, Yasuhiro; Kobayashi, Tsunefumi; Yamanaka, Yoshihiro; Ishiwata, Norihisa; Yamashita, Toru; Tanimoto, Kojiro; Miyoshi, Shunichiro; Fukuda, Keiichi; Nakaya, Haruaki; Ogawa, Satoshi

Yamamoto, Wataru; Hashimoto, Norio; Matsuura, Junji; Machida, Taiichi; Ogino, Yasuhiro; Kobayashi, Tsunefumi; Yamanaka, Yoshihiro; Ishiwata, Norihisa; Yamashita, Toru; Tanimoto, Kojiro; Miyoshi, Shunichiro; Fukuda, Keiichi; Nakaya, Haruaki; Ogawa, Satoshi.

Affiliation

Yamamoto W; *Pharmaceutical Development Research Laboratories, Teijin Institute for Bio-Medical Research, Teijin Pharma Limited, Tokyo, Japan; Pharmaceutical Research Department, Biological Research Laboratories, Nissan Chemical Industries, Ltd, Saitama, Japan; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan; §Department of Pharmacology, Chiba University Graduate School of Medicine, Chiba, Japan; and ¶Mita Hospital, International University of Health and Welfare, Tokyo, Japan.

J Cardiovasc Pharmacol ; 63(5): 421-7, 2014 May.

Article de En | MEDLINE | ID: mdl-24805146

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fibrillation auriculaire / Récepteurs cholinergiques / Inhibiteurs des canaux potassiques / Antiarythmiques Limites: Animals Langue: En Journal: J Cardiovasc Pharmacol Année: 2014 Type de document: Article Pays d'affiliation: Japon Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google